You are here

Article Text

Article menu
Download PDFPDF
What neurologists need to
Deep brain stimulation: practical insights and common queries
  1. Fahd Baig1,2,
  2. Thomas Robb3,
  3. Lucy Mooney1,
  4. Caroline Robbins1,
  5. Caroline Norris1,
  6. Neil Barua1,3,
  7. Konrad Szewczyk-Krolikowski1,
  8. Alan Whone, Consultant Senior Lecturer in Movement Neuroscience1,3
  1. 1 Neurological and Musculoskeletal Sciences Division, Southmead Hospital, North Bristol NHS Trust, Bristol, UK
  2. 2 Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK
  3. 3 Translational Health Sciences, University of Bristol, Bristol, UK
  1. Correspondence to Dr Alan Whone, Movement Disorders Group, Bristol Brain Centre, Southmead Hospital, North Bristol NHS Trust, Bristol, BS10 5NB, UK; alan.whone{at}bristol.ac.uk

Abstract

The number of patients with deep brain stimulation (DBS) devices implanted is increasing. Although practices vary between centres, patients are typically given training and information from their DBS nurse or clinician, as well as a comprehensive device manual and contact details for their device manufacturer. However, for the lifetime of a patient with a DBS system, most of their secondary care often occurs in a centre without a co-located DBS service. The local neurologist is often asked pragmatic questions regarding the do’s and don’ts for patients with DBS systems. While a DBS centre or device manufacturer can provide advice, we thought that it will be helpful to outline the overall management of DBS for movement disorders and the approach to commonly raised questions. We describe briefly the clinical application of DBS and discuss common scenarios where there are possible compatibility issues around the device.

  • Parkinson’s disease
  • movement disorders
  • electrical stimulation

https://doi.org/10.1136/practneurol-2019-002275

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors FB: researched, outlined the scope and drafted the manuscript. TR: researched and helped to draft the manuscript. LM, CR and CN provided expert critique and practical insights. NB provided technical expertise and critiqued the manuscript. KS-K and AW provided expert technique and practical insights. All the authors contributed to the final manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Disclaimer All the authors have approved the final article. FB and TR report no financial disclosures. CN and CR have received conference expenses from Boston Scientific. LM has received honoraria from Boston Scientific, Medtronic, Abbott and AbbVie. KS-K has received travel and conference expenses from Abbvie, Boston and Merz, as well as speaking honoraria from Abbvie. NB has received honoraria from Abbott and Boston Scientific. AW has received costs for attending scientific meetings from Boston Scientific and Medtronic.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned. Externally peer reviewed by Tom Foltynie, London, UK.

    Other content recommended for you